Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,895 | -29,391 | -14,586 | -50,608 | -36,891 |
| Depreciation Amortization | -3,726 | -2,014 | -793 | -605 | -192 |
| Accounts payable and accrued liabilities | -3,660 | -2,608 | -2,799 | 3,971 | 818 |
| Other Working Capital | -3,742 | -4,098 | -6,459 | 6,551 | 4,805 |
| Other Operating Activity | 14,328 | 9,442 | 6,007 | 7,746 | 8,452 |
| Operating Cash Flow | $-39,695 | $-28,669 | $-18,630 | $-32,945 | $-23,008 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -57,564 | -67,691 | -15,763 | -116,839 | -105,716 |
| PPE Investments | -61 | -11 | N/A | -455 | -444 |
| Investing Cash Flow | $-57,625 | $-67,702 | $-15,763 | $-117,294 | $-106,160 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 49,628 | 49,628 | 49,486 | 182 | 70 |
| Financing Cash Flow | $49,628 | $49,628 | $49,486 | $182 | $70 |
| Beginning Cash Position | 94,984 | 94,984 | 94,984 | 245,041 | 245,041 |
| End Cash Position | 47,292 | 48,241 | 110,077 | 94,984 | 115,943 |
| Net Cash Flow | $-47,692 | $-46,743 | $15,093 | $-150,057 | $-129,098 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,695 | -28,669 | -18,630 | -32,945 | -23,008 |
| Capital Expenditure | -61 | -11 | N/A | -455 | -444 |
| Free Cash Flow | -39,756 | -28,680 | -18,630 | -33,400 | -23,452 |